Kistamicin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameKistamicin
Drug Alias NameKistamicin ABU-4344V
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza, HumanGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDupont Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
Active IndicationsN/A
Inactive IndicationsInfluenza, HumanGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A